Alafair Biosciences is a privately held medical device company commercializing a clinically-driven technology platform using natural biopolymers to address postoperative soft tissue recovery. For over 10 years, Alafair has produced HA-rich class II medical devices for the protection of tendon, ligament, skeletal muscle, and peripheral nerve (including nerve root in spine procedures). Alafair’s technology platform is used primarily by hand surgeons, foot & ankle surgeons, and spine surgeons in a wide variety of procedures. Today, Alafair has sold over 10,000 units of its flagship product, VersaWrap®.

Recently, Alafair was featured on the 2023 Inc. 5000 list as one of the fastest-growing private companies in America, ranking at No. 23 among Health Products. This prestigious list provides valuable insight into the most successful companies within the economy’s most dynamic segment—independent, entrepreneurial businesses.

“This is such an exhilarating and transformative time for Alafair. We’ve achieved exceptional growth in the pursuit of improving patient care,” said John Joyoprayitno, Co-Founder, President and CEO of Alafair Biosciences. “From innovative R&D to new partnerships, there is much to celebrate and even more to look forward to.”

“Winstead’s team has been instrumental in guiding and advising Alafair’s leadership through intellectual property protection, strategic partnership negotiations, cap table management, and beyond.”

John Joyoprayitno, Co-Founder, President and CEO of Alafair Biosciences, Inc.